News
Thursday, November 29th, 2012
HealthDay: 11/21/12 WEDNESDAY, Nov. 21 (HealthDay News) — Full body X-ray scanners and luggage X-rays may damage some insulin pumps and continuous glucose monitors, both used by many people with diabetes to manage their conditions. It’s likely that every day, large numbers of travelers expose these diabetes care devices to X-rays while going through airport security […]
News
Thursday, November 29th, 2012
DMS Journal: 11/21 Background The American Diabetes Association (ADA) has published several diabetes treatment algorithms, but none have been tested in real-life settings. The aim of this study is to analyze the feasibility of achieving and/or maintaining HbA1c levels <7.0% using current diabetes treatment guidelines and the resources available in the public health care system of […]
News
Thursday, November 29th, 2012
SAGE: November 21, 2012 Purpose Adults hospitalized with diabetes are likely to have multiple comorbid conditions contributing to suboptimal health-related quality of life. The purpose of this study was to survey urban, very low-income, hospitalized adults with diabetes about disease severity, anticipated disease trajectory, and self-rated health-related quality of life. Methods Data were collected using the Brief […]
News
Thursday, November 29th, 2012
NDEP: 11/14/12 Family health history is an important risk factor for developing type 2 diabetes. Did you know? Nearly 26 million Americans have diabetes. Seven million people with diabetes do not even know that they have this disease. An estimated 79 million adults in the U.S. have prediabetes, placing them at increased risk for developing type […]
Minority Diabetes Reports
Tuesday, November 20th, 2012
Diabetes Journals: 11/16/12 OBJECTIVE Ad36, a human adenovirus, increases adiposity but improves glycemic control in animal models. Similarly, natural Ad36 infection is cross-sectionally associated with greater adiposity and better glycemic control in humans. This study compared longitudinal observations in indices of adiposity (BMI and body fat percentage) and glycemic control (fasting glucose and insulin) in Ad36-infected versus […]
Minority Diabetes Reports
Tuesday, November 20th, 2012
Marketwire: 11/13/12 During November’s Diabetes Awareness Month, APMA Urges Those With Diabetes or at Risk for the Disease to Have Their Feet Examined by a Podiatrist Regularly to Prevent Tragic Complications BETHESDA, MD–(Marketwire – Nov 13, 2012) – More than 8 percent of the entire US population — 26 million people — currently suffer from diabetes. […]
Minority Diabetes Reports
Tuesday, November 20th, 2012
Oxford Journals: 11/9/12 Type 2 diabetes (T2D) is up to twice as prevalent among African Americans as Caucasians. Recent genome-wide association studies (GWAS) have identified multiple common genetic risk variants for T2D; however, none of these studies were conducted exclusively among subjects of African ancestry. Investigating these known loci in other populations would be an expedient […]
Minority Diabetes Reports
Tuesday, November 20th, 2012
TARA BRYANT: 11/2/12 Fred Gipp pounded his feet on the bricks until his feet hurt. His performance outside the Kansas Union on Thursday attracted the attention of students and passersby. Gipp danced to promote a powwow he will perform in next year. He said he dances to stay in shape. And it’s important that Gipp stays […]
Minority Diabetes Reports
Tuesday, November 20th, 2012
Springerlink: 10/5/12 Previous studies have not examined whether documentation status has an effect on healthcare utilization among US Hispanic immigrants with diabetes. A secondary analysis was conducted using data from the Pew Hispanic Center and Robert Johnson Wood Foundation’s 2007 Hispanic Healthcare Survey. Hispanic immigrants diagnosed with diabetes were included in analyses. The association between documentation […]
Clinical Trial News
Tuesday, November 20th, 2012
Diabetes Care: 1/16/12 OBJECTIVE A 12-week study assessed the efficacy and safety of a new oral antidiabetic agent, imeglimin, as add-on therapy in type 2 diabetes patients inadequately controlled with metformin alone. RESEARCH DESIGN AND METHODS A total of 156 patients were randomized 1:1 to receive imeglimin (1,500 mg twice a day) or placebo added to a stable […]